Horizon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Horizon Therapeutics's estimated annual revenue is currently $3B per year.
- Horizon Therapeutics's estimated revenue per employee is $843,786
- Horizon Therapeutics's total funding is $2.7B.
- Horizon Therapeutics's current valuation is $20.7B. (January 2022)
Employee Data
- Horizon Therapeutics has 3508 Employees.
- Horizon Therapeutics grew their employee count by -5% last year.
Horizon Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Group VP M&A and Business Development | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | Sr. VP CM Operations and Supply Chain | Reveal Email/Phone |
5 | Group VP, Field Medical Affairs and Operations | Reveal Email/Phone |
6 | Group VP and General Manager, Gout and Inflammation Business Units | Reveal Email/Phone |
7 | CIO | Reveal Email/Phone |
8 | Head Research and Development Compliance and Standards and Clinical Core Functions | Reveal Email/Phone |
9 | VP Rheumatology Clinical Research | Reveal Email/Phone |
10 | VP New Product Planning | Reveal Email/Phone |
Horizon Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | -14% | N/A | N/A |
#2 | $0.8M | 5 | 0% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $707.3M | 2852 | 14% | $1.1B | N/A |
#5 | $1.7M | 11 | 0% | N/A | N/A |
#6 | $32.6M | 210 | 6% | N/A | N/A |
#7 | $2.6M | 17 | 6% | N/A | N/A |
#8 | $1.1M | 7 | -30% | N/A | N/A |
#9 | $1.4M | 9 | -10% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Horizon Therapeutics?
Horizon Therapeutics is a late stage biopharmaceutical company focused on rapid development of prescription drugs for mild to moderate pain relief. We are creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.
keywords:N/A$2.7B
Total Funding
3508
Number of Employees
$3B
Revenue (est)
-5%
Employee Growth %
$20.7B
Valuation
N/A
Accelerator
Horizon Therapeutics News
Horizon Therapeutics PLC (HZNP) is the highest overall rated company in the Drug Manufacturers - General industry with an overall score of...
Horizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon Prize to Inspire Solutions that...
Horizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022. April 14, 2022 08:00 AM Eastern...
Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc. - First-Quarter 2021 Net Sales of $342.4 Million; First-Quarter 2021 GAAP Net Loss of $123 ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1567.7M | 4552 | 3% | N/A |
#2 | $1258.5M | 5014 | -1% | N/A |
#3 | $1634.6M | 5121 | 4% | N/A |
#4 | $4540M | 5720 | -7% | $181.9M |
#5 | $7400M | 6126 | 3% | N/A |